Skip to content

Breakout Investor

Becoming A Better Investor

30b

Biocon eyes $30b US insulin market via its biosimilars

Biocon eyes $30b US insulin market via its biosimilars

October 25, 2021

Berkshire leads $750m Nubank funding round, values it at $30b

Berkshire leads $750m Nubank funding round, values it at $30b

June 8, 2021

Breakout Investor © 2025. All Rights Reserved.